Your browser doesn't support javascript.
loading
ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.
Belch, Jill; Carlizza, Anita; Carpentier, Patrick H; Constans, Joel; Khan, Faisel; Wautrecht, Jean-Claude; Visona, Adriana; Heiss, Christian; Brodeman, Marianne; Pécsvárady, Zsolt; Roztocil, Karel; Colgan, Mary-Paula; Vasic, Dragan; Gottsäter, Anders; Amann-Vesti, Beatrice; Chraim, Ali; Poredos, Pavel; Olinic, Dan-Mircea; Madaric, Juraj; Nikol, Sigrid; Herrick, Ariane L; Sprynger, Muriel; Klein-Weigel, Peter; Hafner, Franz; Staub, Daniel; Zeman, Zan.
Afiliación
  • Belch J; 1 University of Dundee School of Medicine, Dundee, United Kingdom.
  • Carlizza A; 2 Azienda Ospedaliera S.Giovanni-Addolorata, Rome, Italy.
  • Carpentier PH; 3 Grenoble University Hospital, Grenoble, France.
  • Constans J; 4 Hopital St Andre, Bordeaux, France.
  • Khan F; 1 University of Dundee School of Medicine, Dundee, United Kingdom.
  • Wautrecht JC; 5 Cliniques universitaires de Bruxelles, Brussels, Belgium.
  • Visona A; 6 Angiology Unit, Azienda ULSS 2, Marca Trevigiana, Treviso, Italy.
  • Heiss C; 7 Department of Cardiology, Pulmonology and Vascular Medicine, Düsseldorf, Germany.
  • Brodeman M; 8 Division of Angiology, Medical University, Graz, Austria.
  • Pécsvárady Z; 9 Head of 2nd Dept. of Internal Medicine, Vascular Center, Flor Ferenc Teaching Hospital, Kistarcsa, Hungary.
  • Roztocil K; 10 Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
  • Colgan MP; 11 St. James's Hospital and Trinity College, Dublin, Ireland.
  • Vasic D; 12 Clinical Centre of Serbia, Belgrade, Serbia.
  • Gottsäter A; 13 Department of Vascular Diseases, Skåne University Hospital, Sweden.
  • Amann-Vesti B; 14 Clinic for Angiology, University Hospital Zurich, Switzerland.
  • Chraim A; 15 Department of Vascular Surgery, Cedrus Vein and Vascular Clinic, Lviv Hospital, Lviv, Ukraine.
  • Poredos P; 16 University Medical Centre Ljubljana, Slovenia.
  • Olinic DM; 17 Medical Clinic no. 1, Iuliu Hatieganu, University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Madaric J; 18 National Institute of Heart and Vascular Diseases, Bratislava, Slovakia.
  • Nikol S; 19 Asklepios Klinik St. Georg, Klinische und Interventionelle Angiologie, Hamburg, Germany.
  • Herrick AL; 20 Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom.
  • Sprynger M; 21 Cardiology-Vascular Medicine, Cardiology Department, University Hospital Liège, Liège, France.
  • Klein-Weigel P; 22 Helios Klinik Berlin-Buch, Klinik für Angiologie, Berlin, Germany.
  • Hafner F; 23 Division of Angiology, Medical University, Graz, Austria.
  • Staub D; 24 Department of Angiology, University Hospital Basel, Switzerland.
  • Zeman Z; 25 Department of Clinical Cardiology and Angiology, Hospital Bulovka, Prague, Czech Republic.
Vasa ; 46(6): 413-423, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28895508
ABSTRACT
Regarding the clinical diagnosis of Raynaud's phenomenon and its associated conditions, investigations and treatment are substantial, and yet no international consensus has been published regarding the medical management of patients presenting with this condition. Most knowledge on this topic derives from epidemiological surveys and observational studies; few randomized studies are available, almost all relating to drug treatment, and thus these guidelines were developed as an expert consensus document to aid in the diagnosis and management of Raynaud's phenomenon. This consensus document starts with a clarification about the definition and terminology of Raynaud's phenomenon and covers the differential and aetiological diagnoses as well as the symptomatic treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Raynaud Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Revista: Vasa Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Raynaud Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Revista: Vasa Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido